Invasive meningococcal disease (IMD) is an acute and serious disease that can result in death. Key differences exist between the IMD vaccines that are available in Canada, such as the meningococcal serogroups that they protect against and the age indications for use.
Using a pediatric patient case, this program will review the prevalence of different meningococcal serogroups in Canada, along with the differences between currently available vaccines. The overall goal of the program is to increase clinicians’ confidence in discussing IMD vaccination with their patients and recommending appropriate vaccination.
This CME has been supported by educational funding from GSK Grant.